Objective: There has been an increased awareness of the presence and clinical importance of abdominal compartment syndrome. It is now appreciated that elevations of abdominal pressure occur in a wide variety of critically ill patients. Full-blown abdominal compartment syndrome is a clinical syndrome characterized by progressive intra-abdominal organ dysfunction resulting from elevated intra-abdominal pressure. This review provides a current, clinically focused approach to the diagnosis and management of abdominal compartment syndrome, with a particular emphasis on intensive care. Methods: Source data were obtained from a PubMed search of the medical literature, with an emphasis on the time period after 2000. PubMed "related articles" search strategies were likewise employed frequently. Additional information was derived from the Web site of the World Society of the Abdominal Compartment Syndrome (http://www.wsacs.org). Summary and Conclusions: The detrimental impact of elevated intra-abdominal pressure, progressing to abdominal compart-ment syndrome, is recognized in both surgical and medical intensive care units. The recent international abdominal compartment syndrome consensus conference has helped to define, characterize, and raise awareness of abdominal compartment syndrome. Because of the frequency of this condition, routine measurement of intra-abdominal pressure should be performed in high-risk patients in the intensive care unit. Evidence-based interventions can be used to minimize the risk of developing elevated intra-abdominal pressure and to aggressively treat intraabdominal hypertension when identified. Surgical decompression remains the gold standard for rapid, definitive treatment of fully developed abdominal compartment syndrome, but nonsurgical measures can often effectively affect lesser degrees of intraabdominal hypertension and abdominal compartment syndrome. (Crit Care Med 2008; 36:1304-1310) KEY WORDS: intra-abdominal hypertension; intra-abdominal pressure; compartment syndrome; massive resuscitation; damage control; decompressive laparotomy; temporary abdominal closure
T here has been an increased awareness of the presence and clinical importance of abdominal compartment syndrome (ACS) over the past decade. Whereas this condition was formerly recognized predominately in blunt trauma victims, it is now appreciated that elevations of abdominal pressure occur in a wide variety of critically ill patients. Critical care practitioners need to be familiar with the signs and symptoms of ACS and understand how to treat this increasingly common condition (1). This review provides a current, clinically focused approach to the diagnosis and management of ACS, with a particular emphasis on care in the intensive care unit (ICU).
Full-blown abdominal compartment syndrome is a clinical syndrome characterized by progressive intra-abdominal organ dysfunction resulting from ele-vated intra-abdominal pressure (IAP). The term abdominal compartment syndrome was coined by Kron et al.
(2) in 1984, when they described the pathophysiology following a ruptured abdominal aortic aneurysm. The classic description of ACS included a tense distended abdomen, increased IAP, decreased renal function, elevated peak airway pressure, hypoxia, and inadequate ventilation. Improvement of all variables was seen after decompressive laparotomy.
Definitions
Elevated IAP with progression to ACS has been described in a wide variety of clinical conditions (3-25). A number of authors have promulgated a wide variety of sometimes subtly different definitions and classification schemes (26 -28). The World Society of the Abdominal Compartment Syndrome met in 2004 to try to bring order to this chaotic situation via an international consensus conference. The goal was to produce a consensus statement (accessible at http://www.wsacs. org) related to the definition, diagnosis, and treatment of ACS (29, 30). The consensus statement defines intra-abdominal hypertension (IAH) as an IAP Ն12 mm Hg and ACS as a sustained IAP Ն20 mm Hg that is associated with new organ dysfunction or failure. The society also defined another variable, abdominal perfusion pressure (APP), which may be useful in discussing ACS. This value, which is equal to the mean arterial pressure (MAP) minus the IAP (APP ϭ MAP Ϫ IAP) is a measure of the net pressure available for perfusion of intra-abdominal organs (31). Clinicians can think of APP in the same way that cerebral perfusion pressure is used when discussing brain perfusion in the face of intracranial hypertension. Table 1 compares the current World Society of the Abdominal Compartment Syndrome grading classification of elevated IAP to the previously widely used Burch/Meldrum classification (4, 32). The consensus conference also redefined the zero point for pressure measurements (29, 30). The updated zero point, the midaxillary line, is the same reference point used for most other hemodynamic measurements in the critically ill. IAP should be measured in reference to this point, expressed in mm Hg, and measured at end-expiration in the complete supine position after ensuring that abdominal muscular contractions are absent.
Abdominal compartment syndrome can be classified as either primary ACS (33-35), due to the presence of intraabdominal and/or retroperitoneal pathology, or secondary ACS (17, 35-37), due to generalized capillary leak with massive fluid resuscitation leading to edema of otherwise normal bowel or development of tense ascites. Examples of primary ACS include those associated with damage control laparotomies for trauma or large retroperitoneal hematomas. Secondary ACS is often seen in the postresuscitation phase for septic shock, hemorrhagic shock, or burn injury. Recurrent ACS refers to situations in which ACS redevelops after treatment for either primary or secondary ACS (26, 33).
It is vital to identify and recognize the underlying pathophysiologic conditions, whether primary or secondary (or even tertiary) (38), that produce elevated IAP and that may progress to ACS. In many cases the pathogenesis of ACS is multifactorial, such as primary ACS following abdominal trauma being exacerbated by secondary ACS resulting from massive fluid resuscitation. IAH and ACS share the same pathophysiology, and the clinical distinctions represent points along a continuum. Therefore, when dealing with an individual patient it is critical to identify which pathophysiologic processes are involved in the evolution of IAH/ACS.
Pathophysiology
The abdominal compartment is bounded inferiorly by the pelvic floor, circumferentially by the abdominal wall, and superiorly by the diaphragm, which separates the abdomen from the thorax. Although the diaphragm anatomically divides the chest and abdomen, the diaphragm is not a rigid barrier to transmission of increased pressures within the torso (39), although the tendency is more for intraabdominal processes to affect intrathoracic measurements than in the other direction. The underlying pathophysiology of ACS is consistent with the patho-genesis of compartment syndrome in other body regions (40 -42). The fundamental abnormality, increased pressure within a (relatively) nonexpandable compartment, leads to aberrations in the blood flow of intracompartmental tissues, initially at the microvascular (capillary) level but eventually progressing to affect the venous return and arterial inflow.
In contrast to extremity compartment syndromes, the organ dysfunction from sustained IAH usually becomes clinically significant before actual intra-abdominal organ infarction (e.g., bowel necrosis). However, as with extremity compartment syndromes, there is a threshold of IAH at which the cycle of microvascular derangement becomes self-propagating. This point is reached when elevations in IAP increase venous outflow resistance, leading to venous congestion and further increases of intracompartmental pressures. At the point where IAP is greater than ‫02ف‬ mm Hg, there is a significant reduction in effective perfusion of the capillary beds, leading to tissue ischemia and activation of inflammatory mediators. This in turn leads to increased extravascular fluid loss via capillary leak, producing more tissue fluid influx, a further net increase in intra-abdominal volume, and additional elevation of IAP, perpetuating the cycle. An additional contributing factor in the cycle of IAH/ ACS is the impairment of lymphatic flow and subsequent increase in intestinal edema (43, 44).
The systemic and clinical manifestations of ACS are related to the consequences of IAH at the organ level. Expansion of the abdominal cavity from elevated IAP results in a cephalad displacement of the diaphragm with reduction in dynamic pulmonary compliance and a requirement for increasing positive airway pressure to deliver the same tidal volume (45). The cycle of impaired outflow, decreased capillary perfusion, and increasing pressure also leads to de-creased hepatosplanchnic flow (with impaired liver function) (46 -48), decreased renal blood flow (resulting in low urine output, progressing from oliguria to anuria) (49 -51), compression of the inferior vena cava, and decreased venous return to the heart (with resultant decreased cardiac output, progressing to shock) (52).
Diagnosis
The diagnosis of ACS can be divided into three components: 1) identifying patients at risk; 2) recognizing the clinical signs associated with the transition of IAH to ACS; and 3) proactively carrying out diagnostic measures to confirm the suspected diagnosis. Elevations in IAP, and even the presence of ACS, may be suspected based on computed tomography radiographic findings (53-55). Risk factors for ICU patients can be seen in Table 2 . A variety of means of measuring IAP have been reported, such as gastric pressure via a nasogastric tube (56), inferior vena cava pressure (57), rectal pressure, direct IAP via direct puncture, or use of bedside ultrasound to assess the caliber and respiratory variation of the inferior vena cava (58) , but measurement of IAP using the bladder is the current mainstay of diagnosis (59) . The currently recommended technique involves instillation of 25-50 mL of sterile saline into the bladder via a Foley catheter (29, 60). The catheter tubing is clamped, and a needle is inserted via the specimencollection port proximal to the clamp and attached to a calibrated pressure transducer. Variation in IAP with gentle abdominal pressure confirms that there is good fidelity of pressure transduction. To ensure accuracy and reproducibility, IAP should be measured at end-expiration with the patient completely supine (30). Abdominal muscle contractions should be absent and the transducer is zeroed at the level of midaxillary line. Modifications of this system allow continuous measurement (57, 61, 62) .
Patients who are at risk for possible development of ACS (35, [63] [64] [65] [66] (Table 3) should have baseline measurement of IAP at admission to the ICU. The most common risk factor associated with ACS is a history of massive fluid resuscitation, usually with a significant crystalloid component. In this context, massive is defined as Ͼ5 L of intravenous fluid resuscitation within a 24-hr period. Experienced clinicians will quickly recognize that such a definition of massive resuscitation encompasses a large number of ICU patients, underscoring the importance of always considering the possibility of ACS development and proactively assessing IAP.
Clinical Signs of ACS
The classic constellation of clinical findings associated with ACS includes in-creased airway pressure, decreased urine output, and a tense abdomen on physical exam (2). Unfortunately, from a practical standpoint, these signs and symptoms are extremely nonspecific in critically ill patients. For example, patients undergoing large-volume fluid resuscitation frequently have impaired tissue perfusion, hypotension, and oliguria. These same patients are at risk for acute lung injury or pulmonary edema, either of which may result in increased airway pressure (67, 68) . In many cases the only way to detect ACS is via active monitoring of IAP. This is especially important for the conditions delineated in Table 4 . Factors involved in determining the subsequent interval and duration of IAP monitoring include the baseline pressure measurement, the ability to alter etiologic and risk factors, and the dynamic evolution of the patient's course.
Treatment
To a great extent, the best treatment for ACS is prevention. Increased recognition regarding the risk factors, setting, and pathogenesis of ACS allows earlier identification of at-risk patients. This in turn prompts earlier, more aggressive monitoring of IAP and facilitates the institution of corrective/preventive measures before full-blown ACS develops. Prevention of ACS also involves accurate determination of appropriate end points of resuscitation (69 -74) in order to avoid excess fluid administration. While the specific variables used to determine end points of resuscitation may always be debated, the adage that "if some urine is good, more urine is better" is clearly obsolete. Furthermore, development of ACS is just one of the adverse clinical consequences of overly vigorous fluid administration. In the setting of IAH, traditional measures of preload may be insufficient due to a concomitant increase in intrathoracic pressure. In these cases, more precise measures of ventricular preload, such as those obtained via global enddiastolic volume (obtained via transpulmonary thermodilution) or continuous right ventricular end-diastolic volume, may be used (75, 76) . Once goal-directed resuscitation end points (i.e., decrease in lactate, adequate mixed venous oxygen saturation, decrease in base deficit) are achieved, ongoing aggressive resuscitation should be stopped just as aggressively. Finally, primary ACS can be forestalled by the recognition of patients at risk while still in the operating room. In high-risk patients it may be safest for the surgeon to use prophylactic measures, such as temporary abdominal closure, to allow the abdominal contents to expand more freely (77) (78) (79) (80) . However, when patients return to the ICU with a temporary abdominal closure, it is still imperative that the ICU team avoid overresuscitation. Monitoring the APP during this period may provide guidance in determining the trends during resuscitation, and if it is not possible to maintain an APP Ͼ60, then additional surgical intervention should be considered.
The definitive treatment for fully manifested ACS is surgical decompression via a laparotomy (1, [81] [82] [83] . When performed appropriately, surgical decompression is almost always effective, often immediately and dramatically, with rapid resolution of hypotension, oliguria, and elevated airway pressure. Surgical decompression requires the presence of a surgeon and usually requires general anesthesia. Numerous reports attest to the fact that surgical decompression can be safely performed at the bedside in the ICU (84, 85) , an important factor to consider, since many patients with ACS are clinically unstable. Surgical decompression also involves a surgical stress that may serve as a second hit with respect to the immunoinflammatory status of the patient (86, 87) . Additionally, the rapid resolution of the hemodynamic consequences of ACS may lead to ischemiareperfusion injury to the visceral organs (88) . Successful surgical decompression of ACS creates another problem: how to deal with the open abdominal wound. The rate of unsuccessful reclosure of the abdomen has been reported between 20% and 78% (89 -91) . A substantial number of these patients represent major challenges with respect to coverage of the bowel, prevention and management of enterocutaneous fistulas, and management of large ventral hernias. Because of these potential consequences to an open abdomen, attempts should be made to close the abdomen as soon as the underlying cause of the ACS has been addressed, since the incidence of failed closure and additional complications increases as time passes. This timeframe can be short but varies greatly from patient to patient, and actual timing depends greatly on the assessment of the abdomen by the surgeons involved.
While surgical decompression is unquestionably a rapid and definitive treatment, given the consequences of this pro- cedure there is increasing enthusiasm for nonsurgical treatment options of elevated IAH, IAP, and ACS ( Table 5 ). Many of these measures are employed relatively routinely (e.g., nasogastric decompression and sedation) in critically ill patients. Prokinetic agents, enemas, or placement of a rectal decompression tube will seldom dramatically change IAP and should be used very cautiously in cases where toxic megacolon or inflammatory bowel syndrome is suspected. Likewise, the impact of body positioning should not be underestimated as a potentially confounding variable. Avoiding acute flexion at the hips (even though this is counter to the current ICU guideline to maintain a 30 -45°elevation of the head of the bed) and/or employing reverse Trendelenburg can relieve pressure on the abdomen. Neuromuscular blockade may dramatically decrease IAP and can be administered quickly and safely to intubated ICU patients (28, 29, 92-96). Even small amounts of tension in the abdominal muscles can have a large impact on IAP, and this component can easily be removed with neuromuscular blockade. In many cases, decreases in IAP with neuromuscular blockade may provide sufficient time for other nonoperative measures, such as removal of excess fluid, to be effective.
Excess fluid can and should be aggressively removed (by diuretics or ultrafiltration); however, it is absolutely crucial to ensure that fluid removal does not result in impaired oxygen delivery or systemic or local perfusion. In our practice we often employ invasive hemodynamic monitoring (e.g., pulmonary artery catheter) with continuous measurements of cardiac output and mixed venous oxygen saturation to avoid hypoperfusion and exacerbation of shock. If accessible free fluid is present in the abdomen, percutaneous catheter drainage has been reported to be a successful treatment for ACS (31, 81, (97) (98) (99) (100) . Even with primary ACS there may be moderately large pockets of accessible fluid, and removal of even small volumes can significantly lower IAP (100) . Bedside ultrasound can be useful for identifying a safe window for placing the drainage catheter in the setting of abdominal distension and ACS (97) . Generally, success with catheter drainage is early and dramatic. Therefore, if ACS persists after catheter drainage, definitive treatment (i.e., surgical decompression) should not be delayed in the hope that repositioning the drainage catheter will improve the situation (81) .
Management of the open abdomen following surgical decompression is an area of controversy and ongoing research. There are many modifications of the classic Bogota bag abdominal closure (78, 79, (101) (102) (103) ; the most important consideration when performing a temporary abdominal closure is to allow for additional bowel swelling, thereby avoiding recurrent ACS. When ACS and elevated IAP have resolved, an effort to close the abdomen with autogenous tissue should be made as soon as the capillary leak and edema have resolved (34, 90, 103, 104) . In this phase, aggressive, deliberate diuresis and/or ultrafiltration can be used to remove excess total body water. While the window of opportunity for primary fascial closure may vary from patient to patient, in general it is ‫7ف‬ days; beyond this time the development of adhesions and early granulation tissue often leads to a "frozen abdomen" that precludes fascial closure. The chances of success can be further augmented by progressive incremental closure or increased tension of the temporary closure (80, (105) (106) (107) . Additionally, the use of vacuum-assisted wound devices may aid in closing the abdomen or at least potentially reduce the size of any residual ventral hernia (81, 89) . Clinicians should remain vigilant for the possibility of recurrent ACS during these efforts. Abdominoplasty, in the form of component separation and closure, has also been reported (80, 108, 109) , although these sometimes extensive procedures are usually limited to more stable patients. An excellent review of issues related to management of the open abdomen has been recently published (90) .
CONCLUSIONS
The detrimental impact of elevated IAP, progressing to ACS, is recognized more frequently in both surgical and medical ICUs. Because of the frequency of this condition and the subtle clinical findings, routine measurement of IAP should be performed in all high-risk ICU patients. A number of measures can be employed to minimize the risk of developing elevated IAP and to aggressively treat IAH when identified. Nonsurgical measures can effectively treat lesser degrees of IAH and ACS, but surgical decompression remains the gold standard for rapid, definitive treatment of fully developed ACS. The recent international ACS consensus conference has helped to define, characterize, and raise awareness of this condition. We hope that this review will assist in understanding and recognizing ACS and ultimately will lead to the development of even more effective clinical treatment guidelines (110, 111) . 
